ADIL - Balance Sheet - Adial Pharmaceuticals, Inc.

Current Liabilities	976 K
Accounts Payable	250 K
Short-Term Debt	0
Other Current Liabilities	726 K
Non-Current Liabilities	0
Long-Term Debt	0
Other Non-Current Liabilities	0

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017	Dec-2016	Dec-2015
ASSETS
Cash & Cash Equivalents	3.8	2.8	4.0	6.1	4.4	6.8	3.9	18.2 K	88 K	0.2
Short Term Investments	0	0	0	0	0	0	0	0	0	0
Receivables	0	0	0	0	0	0	0	0	35.1 K	0
Inventory	0	0	0	0	0	0	0	0	0	0
Other Current Assets	0.3	0.4	0.8	0.4	0.7	0.9	0.8	9 K	18.3 K	86.3 K
Total Current Assets	4.1	3.2	4.8	6.5	5.1	7.7	4.7	27.2 K	0.1	0.2
PP&E	0	0	0.2	0.3	0	0	0	0	0	0
Intangible Assets	3.35 K	3.91 K	0.5	0.5	5.61 K	6.17 K	6.74 K	7.3 K	7.86 K	8.43 K
Goodwill	0	0	0.2	0.2	0	0	0	0	0	0
Long Term Investments	1.0	1.5	(0.6)	(0.6)	0.3	0	0	0	0	0
Other Long Term Assets	0	0	0.5	0.5	0	0	0	0	2.25 K	2.25 K
Other Assets	0	0	0	0	0	0	0	0	0	0
Total Assets	5.0	4.7	5.7	7.5	5.5	7.7	4.7	34.5 K	0.2	0.2
LIABILITIES
Accounts Payable	0.3	0.1	0.3	0.3	0.6	0.2	99.7 K	0.3	20 K	37.5 K
Short Term Debt	0	0	0.1	49.6 K	0	0	0	0.7	0.2	0
Other Current Liabilities	0.7	0.5	1.4	2.4	0.9	0.3	0.2	752	752	15.6 K
Total Current Liabilities	1.0	0.7	1.8	2.7	1.5	0.5	0.3	1.0	0.3	53.1 K
Long Term Debt	0	0	0.2	0.2	0	0	0	0	0	0
Deferred Tax Income	0	437	22.9 K	23.4 K	0	0	0	0	0	0
Other Liabilities	0	0	0.5	1.0	0	0	0	0	0	0
Total Liabilities	1.0	0.7	2.5	4.0	1.5	0.5	0.3	1.0	0.3	53.1 K
EQUITY
Common Stock	6.47 K	1.66 K	26.7 K	20.9 K	14.4 K	10.4 K	6.86 K	3.27 K	9.8	9.7
Retained Earnings	(82.0)	(68.8)	(63.7)	(50.9)	(31.5)	(20.6)	(12.0)	(0.4)	(9.9)	(9.5)
Other Accumulative Comprehensive Income/Loss	0	0	0	0	0	0	0	(0.6)	0	0
Total Equity	4.1	4.1	3.3	3.5	4.0	7.1	4.4	(1.0)	(0.1)	0.2
Total Liabilities and Equity	5.0	4.7	5.7	7.5	5.5	7.7	4.7	34.5 K	0.2	0.2
SHARES OUTSTANDING
Common Shares Outstanding	18.6	1.4	1.1	0.7	0.5	0.4	0.2	0.2	0.2	0.2

Free